Generic and biosimilar medicines saved U.S. patients $3.6 trillion in the last decade. Learn how this industry is driving America Forward as a force for healthcare stability and economic resilience.
Quick Links:
Explore three learning tracks over three days of knowledge-sharing, networking and fun!
Generic and biosimilar medicines brought $496 billion in savings in 2025—and $3.6 trillion in savings in the last decade.
Desi’s journey from painful swelling to playing soccer again shows the power of accessible medicines.
Learn how a biosimilar medication helped Eileen stay focused on auditions, not Crohn’s disease.
Generic and biosimilar medicines are a driving force of safety, strength and security in America. These medicines make it possible for patients and communities to thrive.
